Kadlec Robert Peter
SEC insider (Form 3/4/5 filer). CIK 0002047073. Director at MiNK Therapeutics, Inc. (INKT). 7 reported Form 4/5 transactions since Sep 2024; latest on Dec 1, 2025. Located in NEW YORK, NY.
Companies Kadlec Robert Peter has filed insider reports for
- MiNK Therapeutics, Inc. (INKT): Director
Kadlec Robert Peter
CIK: 0002047073
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MiNK Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Dec 1, 2025INKT
MiNK Therapeutics, Inc.
AwardDirect1.2K shares at avg. $11.09$14K - Sep 9, 2025INKT
MiNK Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
3.2K shares- - Sep 2, 2025INKT
MiNK Therapeutics, Inc.
AwardDirect975 shares at avg. $13.86$14K - Jun 2, 2025INKT
MiNK Therapeutics, Inc.
AwardDirect1.9K shares at avg. $7.17$14K - Mar 3, 2025INKT
MiNK Therapeutics, Inc.
AwardDirect1.5K shares at avg. $8.79$14K - Dec 1, 2024INKT
MiNK Therapeutics, Inc.
AwardDirect12.3K shares at avg. $0.73$9K - Oct 30, 2024INKT
MiNK Therapeutics, Inc.
AwardDirectStock Option
41.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | Award | 1,218 | $11.09 | $13,508 | Direct |
| Sep 9, 2025 | INKT MiNK Therapeutics, Inc. | Award Stock Option (Right to Buy) | 3,225 | - | - | Direct |
| Sep 2, 2025 | INKT MiNK Therapeutics, Inc. | Award | 975 | $13.86 | $13,514 | Direct |
| Jun 2, 2025 | INKT MiNK Therapeutics, Inc. | Award | 1,883 | $7.17 | $13,501 | Direct |
| Mar 3, 2025 | INKT MiNK Therapeutics, Inc. | Award | 1,536 | $8.79 | $13,501 | Direct |
| Dec 1, 2024 | INKT MiNK Therapeutics, Inc. | Award | 12,286 | $0.73 | $8,969 | Direct |
| Oct 30, 2024 | INKT MiNK Therapeutics, Inc. | Award Stock Option | 41,745 | - | - | Direct |
1-7 of 7 transactions